Powder: -20°C for 3 years | In solvent: -80°C for 1 year
SB1317 (TG02) is a potent inhibitor of cyclin dependant kinases (CDKs), Janus kinase 2 (JAK2), and Fms-like tyrosine kinase-3 (FLT3).
パッケージサイズ | 在庫状況 | 単価(税別) |
---|---|---|
2 mg | 約5 days | ¥ 15,000 |
5 mg | 約5 days | ¥ 20,500 |
10 mg | 約5 days | ¥ 29,000 |
50 mg | 約5 days | ¥ 85,000 |
100 mg | 約5 days | ¥ 122,000 |
説明 | SB1317 (TG02) is a potent inhibitor of cyclin dependant kinases (CDKs), Janus kinase 2 (JAK2), and Fms-like tyrosine kinase-3 (FLT3). |
別名 | TG02 |
分子量 | 372.46 |
分子式 | C23H24N4O |
CAS No. | 1204918-72-8 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 10 mM
You can also refer to dose conversion for different animals. 詳細
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
SB1317 1204918-72-8 Angiogenesis Cell Cycle/Checkpoint Chromatin/Epigenetic JAK/STAT signaling Stem Cells Tyrosine Kinase/Adaptors FLT JAK CDK TG 02 SB 1317 TG02 TG-02 SB-1317 Inhibitor inhibitor inhibit